InvaTech Pharma Solutions LLC
NDC Database

InvaTech Pharma Solutions LLC

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing Human OTC Drug
  • Total Records 4
  • Latest Marketing Date 2021-01-13
  • Data Source FDA
  • First Marketing Date 2013-09-26
All
4
View
Drug for Further Processing
3
View
Human OTC Drug
1
View
Company Overview

Company

InvaTech Pharma Solutions LLC

Country

U.S.A

Website

Visit Website

Email

corporate@inva-tech.com

Social Profiles

Company Snapshot

InvaTech Pharma Solutions LLC

40 C Cotters Lane, Suite A, East Brunswick, NJ

U.S.A

inva-tech.com/index.html corporate@inva-tech.com View on Map
NDC Records ( 4 records )
2013
26 Sep
Drug for Further Processing NDC: 57631-003

Nonproprietary Name

Diphenhydramine Hydrochloirde Tablets

Dosage Form

TABLET

Strength

25 mg/1

Labeler

InvaTech Pharma Solutions LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

57631-003

Substance

DIPHENHYDRAMINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-09-26

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2013
26 Sep
Drug for Further Processing NDC: 57631-004

Nonproprietary Name

Acetaminophen

Dosage Form

TABLET

Strength

500 mg/1

Labeler

InvaTech Pharma Solutions LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

57631-004

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-09-26

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
13 Jan
Human OTC Drug NDC: 57631-017

Nonproprietary Name

Senna with Docusate (Red)

Dosage Form

TABLET

Strength

50; 8.6 mg/1; mg/1

Labeler

InvaTech Pharma Solutions LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

57631-017

Substance

DOCUSATE; SENNA ALATA LEAF

Product Type

HUMAN OTC DRUG

DEA Schedule

Start Marketing Date

2021-01-13

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
28 Jan
Drug for Further Processing NDC: 57631-108

Nonproprietary Name

Pyridostigmine Bromide Granules DC 16%

Dosage Form

GRANULE

Strength

30 mg/1

Labeler

InvaTech Pharma Solutions LLC

Marketing Category

DRUG FOR FURTHER PROCESSING

57631-108

Substance

PYRIDOSTIGMINE BROMIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-01-28

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    6 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Drug for Further Processing
  • Human OTC Drug
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

57631-003

Nonproprietary Name

Diphenhydramine Hydrochloirde Tablets

Labeler

InvaTech Pharma Solutions LLC

Dosage Form

TABLET

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit